RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Honolulu, HI · +42 more sites
3 recruiting multiple sclerosis studies with a site in Honolulu, HI.
Sponsor: Novartis Pharmaceuticals
Honolulu, HI · +42 more sites
Sponsor: TG Therapeutics, Inc.
Honolulu, HI · +108 more sites
Sponsor: Reunion Neuroscience Inc
Honolulu, HI · +31 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.